Incyte Corp
Change company Symbol lookup
Select an option...
INCY Incyte Corp
ARVN Arvinas Inc
PAYX Paychex Inc
PYR Pyrogenesis Canada Inc
PM Philip Morris International Inc
GWAV Greenwave Technology Solutions Inc
SLNO Soleno Therapeutics Inc
VRPX Virpax Pharmaceuticals Inc
FDCFF Forum Energy Metals Corp
AFMD Affimed NV
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company also conducts commercial and clinical development operations from its European headquarters in Morges, Switzerland, and Japanese office in Tokyo and Canadian headquarters in Montreal. It operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. The other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib) and ICLUSIG (ponatinib), as well as other clinical development programs. Its Dermatology commercial franchise is comprised of OPZELURA (ruxolitinib) cream.

Closing Price
$59.11
Day's Change
-0.17 (-0.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
59.85
Day's Low
58.74
Volume
(Light)
Volume:
1,118,242

10-day average volume:
2,130,367
1,118,242
  • Prev Close
    59.28
  • Today's Open
    59.46
  • Day's Range
    58.74-59.85
  • Avg Vol (10-day)
    2.1M
  • Last (time)
    4:00p ET 09/27/23
  • Last (size)
    225
  • 52-Wk Range
    57.90 - 86.29
    LowHigh
  • (01/26/23 - 09/25/23)
    2.09%
  • 22.3%
  • Market Cap
    13.2B
  • Shares Outstanding
    224.1M
  • 1.63
  • 36.42x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 94.92
  • (% of float 09/15/23)
    2.94

Latest News

September 27, 2023
5:16 pm ET
MarketWatch
September 26, 2023
5:16 pm ET
MarketWatch
September 25, 2023
5:16 pm ET
MarketWatch
September 22, 2023
5:16 pm ET
MarketWatch
September 21, 2023
5:15 pm ET
MarketWatch
September 20, 2023
5:16 pm ET
MarketWatch
September 19, 2023
5:16 pm ET
MarketWatch
7:24 am ET
Zacks
September 18, 2023
5:15 pm ET
MarketWatch
8:12 am ET
MarketWatch
September 15, 2023
5:15 pm ET
MarketWatch
September 14, 2023
5:15 pm ET
MarketWatch
September 13, 2023
5:15 pm ET
MarketWatch
9:00 am ET
BusinessWire
September 12, 2023
5:16 pm ET
MarketWatch
September 11, 2023
5:16 pm ET
MarketWatch
September 08, 2023
5:15 pm ET
MarketWatch
September 07, 2023
5:16 pm ET
MarketWatch
September 06, 2023
5:16 pm ET
MarketWatch
September 05, 2023
5:15 pm ET
MarketWatch
September 01, 2023
5:15 pm ET
MarketWatch
August 31, 2023
5:16 pm ET
MarketWatch
10:31 am ET
Zacks
August 30, 2023
5:15 pm ET
MarketWatch
August 29, 2023
5:16 pm ET
MarketWatch
August 28, 2023
5:16 pm ET
MarketWatch
August 25, 2023
5:21 pm ET
MarketWatch
August 24, 2023
5:15 pm ET
MarketWatch
August 23, 2023
5:15 pm ET
MarketWatch
August 22, 2023
5:16 pm ET
MarketWatch
8:00 am ET
BusinessWire
August 21, 2023
5:15 pm ET
MarketWatch
August 18, 2023
5:15 pm ET
MarketWatch
August 17, 2023
5:15 pm ET
MarketWatch
August 16, 2023
5:16 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.